Assessing long-term response to teprotumumab in thyroid eye disease

Category Primary study
JournalJournal of Managed Care and Specialty Pharmacy
Year 2020
This article has no abstract
Epistemonikos ID: 337e2e5887f120472830a9ba39ed64c7d42a509e
First added on: Feb 12, 2025